Report Detail

Request for Sample of this report

Pharma & Healthcare Global Antipyretic Medicine for Elderly Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4649451
    • |
  • 18 November, 2025
    • |
  • Global
    • |
  • 133 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Antipyretic Medicine for Elderly market size was valued at US$ 9867 million in 2024 and is forecast to a readjusted size of USD 11030 million by 2031 with a CAGR of 1.9% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Antipyretics for the elderly are antipyretics designed specifically for the elderly, and are mainly used to treat fever symptoms caused by infection (such as influenza, pneumonia), inflammation or other diseases. Its core goal is to lower body temperature by regulating the body temperature center or promoting heat dissipation, while strictly taking into account the physiological characteristics of the elderly and drug safety to avoid adverse drug reactions.
This report is a detailed and comprehensive analysis for global Antipyretic Medicine for Elderly market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antipyretic Medicine for Elderly market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Antipyretic Medicine for Elderly market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Antipyretic Medicine for Elderly market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2020-2031
Global Antipyretic Medicine for Elderly market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antipyretic Medicine for Elderly
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antipyretic Medicine for Elderly market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Antipyretic Medicine for Elderly market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Acetaminophen
Ibuprofen
Other
Market segment by Application
Online Sales
Offline Sales
Major players covered
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
Mallinckrodt
Farmson
Granules India
SKPL
Atabay
Temad
Anqiu Lu'an
Zhejiang Kangle
Hebei Jiheng
Novacyl
Anhui Fubore
Anhui BBCA Likang
Changshu Huagang
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antipyretic Medicine for Elderly product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antipyretic Medicine for Elderly, with price, sales quantity, revenue, and global market share of Antipyretic Medicine for Elderly from 2020 to 2025.
Chapter 3, the Antipyretic Medicine for Elderly competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antipyretic Medicine for Elderly breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Antipyretic Medicine for Elderly market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antipyretic Medicine for Elderly.
Chapter 14 and 15, to describe Antipyretic Medicine for Elderly sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Antipyretic Medicine for Elderly Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Acetaminophen
    • 1.3.3 Ibuprofen
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Antipyretic Medicine for Elderly Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Online Sales
    • 1.4.3 Offline Sales
  • 1.5 Global Antipyretic Medicine for Elderly Market Size & Forecast
    • 1.5.1 Global Antipyretic Medicine for Elderly Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Antipyretic Medicine for Elderly Sales Quantity (2020-2031)
    • 1.5.3 Global Antipyretic Medicine for Elderly Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Xinhua Pharmaceutical
    • 2.1.1 Xinhua Pharmaceutical Details
    • 2.1.2 Xinhua Pharmaceutical Major Business
    • 2.1.3 Xinhua Pharmaceutical Antipyretic Medicine for Elderly Product and Services
    • 2.1.4 Xinhua Pharmaceutical Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Xinhua Pharmaceutical Recent Developments/Updates
  • 2.2 IOLCP
    • 2.2.1 IOLCP Details
    • 2.2.2 IOLCP Major Business
    • 2.2.3 IOLCP Antipyretic Medicine for Elderly Product and Services
    • 2.2.4 IOLCP Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 IOLCP Recent Developments/Updates
  • 2.3 Granules Biocause
    • 2.3.1 Granules Biocause Details
    • 2.3.2 Granules Biocause Major Business
    • 2.3.3 Granules Biocause Antipyretic Medicine for Elderly Product and Services
    • 2.3.4 Granules Biocause Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Granules Biocause Recent Developments/Updates
  • 2.4 Strides Shasun
    • 2.4.1 Strides Shasun Details
    • 2.4.2 Strides Shasun Major Business
    • 2.4.3 Strides Shasun Antipyretic Medicine for Elderly Product and Services
    • 2.4.4 Strides Shasun Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Strides Shasun Recent Developments/Updates
  • 2.5 Mallinckrodt
    • 2.5.1 Mallinckrodt Details
    • 2.5.2 Mallinckrodt Major Business
    • 2.5.3 Mallinckrodt Antipyretic Medicine for Elderly Product and Services
    • 2.5.4 Mallinckrodt Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Mallinckrodt Recent Developments/Updates
  • 2.6 Farmson
    • 2.6.1 Farmson Details
    • 2.6.2 Farmson Major Business
    • 2.6.3 Farmson Antipyretic Medicine for Elderly Product and Services
    • 2.6.4 Farmson Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Farmson Recent Developments/Updates
  • 2.7 Granules India
    • 2.7.1 Granules India Details
    • 2.7.2 Granules India Major Business
    • 2.7.3 Granules India Antipyretic Medicine for Elderly Product and Services
    • 2.7.4 Granules India Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Granules India Recent Developments/Updates
  • 2.8 SKPL
    • 2.8.1 SKPL Details
    • 2.8.2 SKPL Major Business
    • 2.8.3 SKPL Antipyretic Medicine for Elderly Product and Services
    • 2.8.4 SKPL Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 SKPL Recent Developments/Updates
  • 2.9 Atabay
    • 2.9.1 Atabay Details
    • 2.9.2 Atabay Major Business
    • 2.9.3 Atabay Antipyretic Medicine for Elderly Product and Services
    • 2.9.4 Atabay Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Atabay Recent Developments/Updates
  • 2.10 Temad
    • 2.10.1 Temad Details
    • 2.10.2 Temad Major Business
    • 2.10.3 Temad Antipyretic Medicine for Elderly Product and Services
    • 2.10.4 Temad Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Temad Recent Developments/Updates
  • 2.11 Anqiu Lu'an
    • 2.11.1 Anqiu Lu'an Details
    • 2.11.2 Anqiu Lu'an Major Business
    • 2.11.3 Anqiu Lu'an Antipyretic Medicine for Elderly Product and Services
    • 2.11.4 Anqiu Lu'an Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Anqiu Lu'an Recent Developments/Updates
  • 2.12 Zhejiang Kangle
    • 2.12.1 Zhejiang Kangle Details
    • 2.12.2 Zhejiang Kangle Major Business
    • 2.12.3 Zhejiang Kangle Antipyretic Medicine for Elderly Product and Services
    • 2.12.4 Zhejiang Kangle Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Zhejiang Kangle Recent Developments/Updates
  • 2.13 Hebei Jiheng
    • 2.13.1 Hebei Jiheng Details
    • 2.13.2 Hebei Jiheng Major Business
    • 2.13.3 Hebei Jiheng Antipyretic Medicine for Elderly Product and Services
    • 2.13.4 Hebei Jiheng Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Hebei Jiheng Recent Developments/Updates
  • 2.14 Novacyl
    • 2.14.1 Novacyl Details
    • 2.14.2 Novacyl Major Business
    • 2.14.3 Novacyl Antipyretic Medicine for Elderly Product and Services
    • 2.14.4 Novacyl Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Novacyl Recent Developments/Updates
  • 2.15 Anhui Fubore
    • 2.15.1 Anhui Fubore Details
    • 2.15.2 Anhui Fubore Major Business
    • 2.15.3 Anhui Fubore Antipyretic Medicine for Elderly Product and Services
    • 2.15.4 Anhui Fubore Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Anhui Fubore Recent Developments/Updates
  • 2.16 Anhui BBCA Likang
    • 2.16.1 Anhui BBCA Likang Details
    • 2.16.2 Anhui BBCA Likang Major Business
    • 2.16.3 Anhui BBCA Likang Antipyretic Medicine for Elderly Product and Services
    • 2.16.4 Anhui BBCA Likang Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Anhui BBCA Likang Recent Developments/Updates
  • 2.17 Changshu Huagang
    • 2.17.1 Changshu Huagang Details
    • 2.17.2 Changshu Huagang Major Business
    • 2.17.3 Changshu Huagang Antipyretic Medicine for Elderly Product and Services
    • 2.17.4 Changshu Huagang Antipyretic Medicine for Elderly Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Changshu Huagang Recent Developments/Updates

3 Competitive Environment: Antipyretic Medicine for Elderly by Manufacturer

  • 3.1 Global Antipyretic Medicine for Elderly Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Antipyretic Medicine for Elderly Revenue by Manufacturer (2020-2025)
  • 3.3 Global Antipyretic Medicine for Elderly Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Antipyretic Medicine for Elderly by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Antipyretic Medicine for Elderly Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Antipyretic Medicine for Elderly Manufacturer Market Share in 2024
  • 3.5 Antipyretic Medicine for Elderly Market: Overall Company Footprint Analysis
    • 3.5.1 Antipyretic Medicine for Elderly Market: Region Footprint
    • 3.5.2 Antipyretic Medicine for Elderly Market: Company Product Type Footprint
    • 3.5.3 Antipyretic Medicine for Elderly Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Antipyretic Medicine for Elderly Market Size by Region
    • 4.1.1 Global Antipyretic Medicine for Elderly Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Antipyretic Medicine for Elderly Consumption Value by Region (2020-2031)
    • 4.1.3 Global Antipyretic Medicine for Elderly Average Price by Region (2020-2031)
  • 4.2 North America Antipyretic Medicine for Elderly Consumption Value (2020-2031)
  • 4.3 Europe Antipyretic Medicine for Elderly Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Antipyretic Medicine for Elderly Consumption Value (2020-2031)
  • 4.5 South America Antipyretic Medicine for Elderly Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Antipyretic Medicine for Elderly Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Antipyretic Medicine for Elderly Sales Quantity by Type (2020-2031)
  • 5.2 Global Antipyretic Medicine for Elderly Consumption Value by Type (2020-2031)
  • 5.3 Global Antipyretic Medicine for Elderly Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Antipyretic Medicine for Elderly Sales Quantity by Application (2020-2031)
  • 6.2 Global Antipyretic Medicine for Elderly Consumption Value by Application (2020-2031)
  • 6.3 Global Antipyretic Medicine for Elderly Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Antipyretic Medicine for Elderly Sales Quantity by Type (2020-2031)
  • 7.2 North America Antipyretic Medicine for Elderly Sales Quantity by Application (2020-2031)
  • 7.3 North America Antipyretic Medicine for Elderly Market Size by Country
    • 7.3.1 North America Antipyretic Medicine for Elderly Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Antipyretic Medicine for Elderly Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Antipyretic Medicine for Elderly Sales Quantity by Type (2020-2031)
  • 8.2 Europe Antipyretic Medicine for Elderly Sales Quantity by Application (2020-2031)
  • 8.3 Europe Antipyretic Medicine for Elderly Market Size by Country
    • 8.3.1 Europe Antipyretic Medicine for Elderly Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Antipyretic Medicine for Elderly Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Antipyretic Medicine for Elderly Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Antipyretic Medicine for Elderly Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Antipyretic Medicine for Elderly Market Size by Region
    • 9.3.1 Asia-Pacific Antipyretic Medicine for Elderly Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Antipyretic Medicine for Elderly Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Antipyretic Medicine for Elderly Sales Quantity by Type (2020-2031)
  • 10.2 South America Antipyretic Medicine for Elderly Sales Quantity by Application (2020-2031)
  • 10.3 South America Antipyretic Medicine for Elderly Market Size by Country
    • 10.3.1 South America Antipyretic Medicine for Elderly Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Antipyretic Medicine for Elderly Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Antipyretic Medicine for Elderly Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Antipyretic Medicine for Elderly Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Antipyretic Medicine for Elderly Market Size by Country
    • 11.3.1 Middle East & Africa Antipyretic Medicine for Elderly Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Antipyretic Medicine for Elderly Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Antipyretic Medicine for Elderly Market Drivers
  • 12.2 Antipyretic Medicine for Elderly Market Restraints
  • 12.3 Antipyretic Medicine for Elderly Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Antipyretic Medicine for Elderly and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Antipyretic Medicine for Elderly
  • 13.3 Antipyretic Medicine for Elderly Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Antipyretic Medicine for Elderly Typical Distributors
  • 14.3 Antipyretic Medicine for Elderly Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Antipyretic Medicine for Elderly. Industry analysis & Market Report on Antipyretic Medicine for Elderly is a syndicated market report, published as Global Antipyretic Medicine for Elderly Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Antipyretic Medicine for Elderly market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo